LONDON, England, Oct. 19-- The British Insurance Brokers' Association issued the following news release: The British Insurance Brokers' Association (BIBA) has launched a new framework to help members ...

Much of the biopharmaceutical industry this week is focused on the J.P. Morgan Healthcare Conference (JPM), where business leaders are investing in science and technologies with the potential to ...

Alan Balch, PhD: What ICER is trying to do is more like the Abacus. It is meant to be focused at policy makers and thought leaders, and to have a conversation about value-based pricing—as opposed to ...

A reaction to Institute for Clinical and Economic Review's value assessment framework by Eleanor M. Perfetto, PhD, MS, of The National Health Council. “ICER’s Value Assessment Framework: Capturing the ...

The Institute for Clinical and Economic Review’s traditional value assessment methodologies for complex conditions such as Alzheimer’s disease fail to address the full burden on patients, caregivers ...

Trying to gauge the value of new drugs and devices is becoming increasingly important in the U.S. health care system, something that other countries have done explicitly for years. Pressure to get ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

We read with great interest the article by Schnipper et al. 1 This contribution of the American Society of Clinical Oncology (ASCO) is a significant advancement toward ensuring value for patients with ...